Author:
Muñoz A. Arnaiz,Olivas O.,Erkoreka L.,Gaton M.A.,Barreiro A.,Rodriguez J.,Arrue A.,Basterreche N.,Zumarraga M.
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference5 articles.
1. Hyperprolactinemia associated with psychotropics-a review;Madhusoodanan;Hum. Psychopharmacol.,2010
2. The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review;Peuskens;CNS Drugs,2014
3. Prolactin Deficiency by Aripiprazole;Lozano;J. Clin. Psychopharmacol.,2014
4. Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia;Montejo;Rev. Psiquiatr. Salud Ment.,2016
5. Diagnosis and management of hyperprolactinemia;Serri;CMAJ Can. Med. Assoc. J. J. Assoc. Medicale Can.,2003